These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32086179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M, Griffiths P, Mattick RP, Hickman M, Larney S.
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [Abstract] [Full Text] [Related]

  • 3. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
    Graham S, Maher L, Wand H, Doyle M, Iversen J.
    Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
    [Abstract] [Full Text] [Related]

  • 4. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
    Solomon SS, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Sachdeva KS, Lucas GM, Mehta SH.
    J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
    [Abstract] [Full Text] [Related]

  • 5. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A, Hickman M, Colledge-Frisby S, Leung J, Grebely J, Larney S, Degenhardt L, Trickey A.
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
    Hope VD, Harris RJ, Vickerman P, Platt L, Shute J, Cullen KJ, Ijaz S, Mandal S, Ncube F, Desai M, Parry JV.
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S, Mumtaz GR, Chemaitelly H, Al Kanaani Z, Kouyoumjian SP, Hermez JG, Abu-Raddad LJ.
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, Willing A, Kairouz A, Cunningham EB, Hajarizadeh B, Leung J, Tran LT, Price O, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Grebely J.
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis.
    Muller A, Vlahov D, Akiyama MJ, Kurth A.
    Int J Environ Res Public Health; 2020 Jul 09; 17(14):. PubMed ID: 32659974
    [Abstract] [Full Text] [Related]

  • 15. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
    Rashti R, Alavian SM, Moradi Y, Sharafi H, Mohamadi Bolbanabad A, Roshani D, Moradi G.
    Arch Virol; 2020 Sep 09; 165(9):1947-1958. PubMed ID: 32617764
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H, Essa S, Ezzikouri S, Al-Nakib W.
    Sci Rep; 2019 Apr 18; 9(1):6292. PubMed ID: 31000775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study.
    Stone J, Artenie A, Hickman M, Martin NK, Degenhardt L, Fraser H, Vickerman P.
    Lancet Public Health; 2022 Feb 18; 7(2):e136-e145. PubMed ID: 35012711
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM, Solomon SS, Lucas GM, Celentano DD, Srikrishnan AK, Kumar MS, Mehta SH.
    Addiction; 2017 Aug 18; 112(8):1480-1487. PubMed ID: 28317210
    [Abstract] [Full Text] [Related]

  • 20. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, Mamtani R.
    World J Gastroenterol; 2018 Jul 21; 24(27):3038-3054. PubMed ID: 30038471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.